Prognostic Value of Serum Biomarkers in Patients with Idiopathic Pulmonary Fibrosis in Relation to Disease Progression

被引:7
|
作者
Domvri, Kalliopi [1 ,2 ]
Organtzis, Ioannis [2 ]
Apostolopoulos, Apostolos [1 ]
Fouka, Evangelia [2 ]
Kontakiotis, Theodoros [2 ]
Papakosta, Despoina [1 ,2 ]
机构
[1] Aristotle Univ Thessaloniki, George Papanikolaou Hosp, Med Sch, Pulm Dept,Lung Immunol & Bronchoalveolar Lavage Un, Thessaloniki 57010, Greece
[2] Aristotle Univ Thessaloniki, George Papanikolaou Hosp, Med Sch, Pulm Dept,Out Patient Clin ILDs, Thessaloniki 57010, Greece
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 09期
关键词
biomarkers; prognostic; lung; fibrosis; serum; BLOOD BIOMARKERS; BASE-LINE; PIRFENIDONE; DIAGNOSIS;
D O I
10.3390/jpm13091307
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The aim of this present study was to determine serum biomarker levels and their correlation with respiratory function and the clinical course of patients with idiopathic pulmonary fibrosis (IPF). Materials and Methods: This study included 72 IPF patients, according to the ATS/ERS criteria, in whom antifibrotic treatment was initiated. Blood samples were taken, and serum biomarkers, such as KL-6, SP-D, CCL18, CXCL13, VEGF-A, IL-8, IGFBP-1, IGFBP-2, IGFBP-7 and ICAM-1 were measured using ELISA methodology. Pulmonary function tests (FVC, TLC, DLCO-% pred) were determined at baseline and after 12 and 24 months and analyzed in correlation with the biomarkers. Results: The majority of patients (mean age 72 +/- 6 years) were men (83%). The FVC and DLCO values at the 12-month follow-up were found to be statistically decreased in deceased patients (p < 0.05). The SP-D (p < 0.001) and the IGFBP-1 (p = 0.021) levels were found to be increased at the 1-year follow-up in deceased patients, and similarly, the SP-D (p = 0.005) and ICAM-1 (p = 0.043) levels at the 2-year follow-up. A chi-square test revealed that 70% of the category IV GAP index was found with cut-off elevated levels of a biomarker combination (KL-6, SP-D, VEGF-A) from the ROC curve analysis (p < 0.05). Conclusion: This study provides evidence, for the first time in a Greek population, of the possibility of using a combination of KL-6, SP-D, and VEGF-A serum levels along with the GAP index.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression
    Domvri, Kalliopi
    Apostolopoulos, Apostolos
    Organtzis, Ioannis
    Fouka, Evangelia
    Bina, Lamprini
    Kontakiotis, Theodoros
    Papakosta, Despoina
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
    Zhu, Weiwei
    Liu, Chunquan
    Tan, Chunting
    Zhang, Jie
    HELIYON, 2024, 10 (01)
  • [3] Prognostic Value Of Peripheral Blood Biomarkers In Idiopathic Pulmonary Fibrosis
    Song, J. W.
    Kim, M. Y.
    Jang, S. J.
    Colby, T. V.
    Kim, D. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [4] Vimentin serum biomarkers are differentially related to disease progression in idiopathic pulmonary fibrosis (IPF)
    Simoes, Filipa B.
    Hoyer, Nils
    Prior, Thomas S.
    Jessen, Henrik
    Fredriksen, Peder
    Karsdal, Morten
    Leeming, Diana J.
    Bendstrup, Elisabeth
    Sand, Jannie M. B.
    Shaker, Saher B.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis
    Inchingolo, Riccardo
    Varone, Francesco
    Sgalla, Giacomo
    Richeldi, Luca
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (01) : 39 - 51
  • [6] Serum biomarkers in idiopathic pulmonary fibrosis
    van den Blink, Bernt
    Wijsenbeek, Marlies S.
    Hoogsteden, Henk C.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (06) : 515 - 520
  • [7] Serum biomarkers in idiopathic pulmonary fibrosis
    Patrucco, Filippo
    Bellan, Mattia
    Solidoro, Paolo
    PANMINERVA MEDICA, 2021, 63 (02) : 199 - 200
  • [8] The Prognostic Value Of Serum S100a12 In Patients With Idiopathic Pulmonary Fibrosis
    Yamamoto, Y.
    Handa, T.
    Nakatsuka, Y.
    Tanizawa, K.
    Sokai, A.
    Ikezoe, K.
    Tokuda, S.
    Nagai, S.
    Chin, K.
    Hirai, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [9] Evaluating the Prognostic Blood Biomarkers in Patients with idiopathic pulmonary Fibrosis
    Lichert, Frank
    PNEUMOLOGIE, 2022, 76 (10):
  • [10] Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
    Gui, Xianhua
    Qiu, Xiaohua
    Xie, Miaomiao
    Tian, Yaqiong
    Min, Cao
    Huang, Mei
    Hongyan, Wu
    Chen, Tingting
    Zhang, Xin
    Chen, Jingyu
    Cao, Mengshu
    Cai, Hourong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020